Alpine Global Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
Alpine Global Management's NVAX Position: Q3 2024 in Review
Alpine Global Management sold out of Novavax (NVAX) in Q3 2024, closing a stake of 30,141 shares — an estimated $382K sold.
Alpine Global Management first reported a position in NVAX in Q3 2020 and held it in 4 quarters. The position peaked at $382K in Q2 2024. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.
- Alpine Global Management reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
- Alpine Global Management sold 30,141 Novavax shares in Q3 2024, an estimated $382K.
- Alpine Global Management first reported a position in Novavax in Q3 2020 and held it in 4 quarters.
- Alpine Global Management's Novavax position peaked at $382K in Q2 2024.
- 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.
Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.